ANKRD20A9P: A Potential Drug Target and Biomarker (G284232)

Target Name: ANKRD20A9P

NCBI ID: G284232

ANKRD20A9P

Other Name(s): Ankyrin repeat domain 20 family, member A9, pseudogene | ankyrin repeat domain 20 family member A9, pseudogene

ANKRD20A9P: A Potential Drug Target and Biomarker

Ankyrin repeat domains (ANKRDs) are a family of transmembrane proteins that possess unique features such as their ability to form a stable cytoplasmic complex, their prevalence in various organisms, and their involvement in various cellular processes. One of the ANKRD families, ANKRD20A9P, has been identified as a potential drug target and biomarker. In this article, we will explore the ANKRD20A9P protein, its functions, potential drug targets, and its potential as a biomarker for various diseases.

Family Background

The ANKRD family is a subgroup of the ANKRD2 family, which is characterized by the presence of an ANKRD20A9P gene in most organisms. The ANKRD20A9P gene is a member of the ANKRD2 gene family, which is characterized by the presence of a unique repeat domain, named ANKRD20, in the cytoplasmic region of the protein.

The ANKRD20A9P gene is located on chromosome 16p13.3 and has a length of 194 amino acids. It is a single exon gene, which means that it has only one gene product. The ANKRD20A9P protein is a transmembrane protein that has a cytoplasmic region, a N-terminal region, a unique repeat domain, and a C-terminal region.

The ANKRD20A9P protein is involved in various cellular processes, including the regulation of intracellular signaling pathways, cell adhesion, and the regulation of ion channels. It is a protein that has been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Potential Drug Target

The ANKRD20A9P protein is a potential drug target due to its unique features and its involvement in various diseases. One of the reasons for its potential as a drug target is its unique structure, which allows it to form a stable cytoplasmic complex with various signaling molecules. This structure also makes it a good target for small molecules that can modulate its activity.

Ankyrin repeat domains are known for their ability to form a stable cytoplasmic complex with various signaling molecules, including G protein-coupled receptors (GPCRs), beta-adrenergic receptors, and ion channels. The ANKRD20A9P protein is no exception. It has been shown to form a stable cytoplasmic complex with GPCRs, such as the epidermal growth factor receptor (EGFR), which plays a role in cancer progression.

In addition to its involvement with GPCRs, the ANKRD20A9P protein is also involved in the regulation of ion channels, which are important for the regulation of various cellular processes, including muscle contractions, nerve signals, and brain activity. The ANKRD20A9P protein is involved in the regulation of the sodium/calcium ion channel, which is a critical channel for neural signals.

Potential Biomarker

The ANKRD20A9P protein is also a potential biomarker for various diseases. Its involvement in various cellular processes makes it a potential target for small molecules that can modulate its activity. This protein can be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the potential applications of the ANKRD20A9P protein as a biomarker is its ability to be affected by small molecules that target its activity. For instance,

Protein Name: Ankyrin Repeat Domain 20 Family Member A9, Pseudogene

The "ANKRD20A9P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD20A9P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets